These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 27468191)

  • 41. Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.
    Park EK; Lee JC; Park JW; Bang SY; Yi SA; Kim BK; Park JH; Kwon SH; You JS; Nam SW; Cho EJ; Han JW
    Cell Death Dis; 2015 Nov; 6(11):e1964. PubMed ID: 26539911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression.
    Nuzhat Z; Kinhal V; Sharma S; Rice GE; Joshi V; Salomon C
    Oncotarget; 2017 Mar; 8(10):17279-17291. PubMed ID: 27999198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer.
    Donnarumma E; Fiore D; Nappa M; Roscigno G; Adamo A; Iaboni M; Russo V; Affinito A; Puoti I; Quintavalle C; Rienzo A; Piscuoglio S; Thomas R; Condorelli G
    Oncotarget; 2017 Mar; 8(12):19592-19608. PubMed ID: 28121625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
    Hao J; Zhang Y; Deng M; Ye R; Zhao S; Wang Y; Li J; Zhao Z
    Int J Cancer; 2014 Sep; 135(5):1019-27. PubMed ID: 24500893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pancreatic cancer stem cells: features and detection methods.
    Ishiwata T; Matsuda Y; Yoshimura H; Sasaki N; Ishiwata S; Ishikawa N; Takubo K; Arai T; Aida J
    Pathol Oncol Res; 2018 Oct; 24(4):797-805. PubMed ID: 29948612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of stem cell derived exosomes in tumor biology.
    Sharma A
    Int J Cancer; 2018 Mar; 142(6):1086-1092. PubMed ID: 28983919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development.
    Dzobo K; Ganz C; Thomford NE; Senthebane DA
    OMICS; 2021 Feb; 25(2):81-92. PubMed ID: 33170084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells.
    Dioufa N; Clark AM; Ma B; Beckwitt CH; Wells A
    Mol Cancer; 2017 Nov; 16(1):172. PubMed ID: 29137633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
    Arvai KJ; Hsu YH; Lee LA; Jones D
    PLoS One; 2015; 10(6):e0131108. PubMed ID: 26098881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ever-changing landscape of pancreatic cancer stem cells.
    Sancho P; Alcala S; Usachov V; Hermann PC; Sainz B
    Pancreatology; 2016; 16(4):489-96. PubMed ID: 27161173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
    Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M
    Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pancreatic cancer and associated exosomes.
    Zhao C; Gao F; Weng S; Liu Q
    Cancer Biomark; 2017 Dec; 20(4):357-367. PubMed ID: 29036786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of exosomes in the promotion of epithelial-to-mesenchymal transition and metastasis.
    Visan KS; Lobb RJ; Moller A
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1022-1057. PubMed ID: 32114423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer stem cells in colorectal cancer: a review.
    Munro MJ; Wickremesekera SK; Peng L; Tan ST; Itinteang T
    J Clin Pathol; 2018 Feb; 71(2):110-116. PubMed ID: 28942428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer stem cell-derived exosome-induced metastatic cancer: An orchestra within the tumor microenvironment.
    Rashid K; Ahmad A; Meerasa SS; Khan AQ; Wu X; Liang L; Cui Y; Liu T
    Biochimie; 2023 Sep; 212():1-11. PubMed ID: 37011805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular Mechanisms Underlying the Functions of Cellular Markers Associated with the Phenotype of Cancer Stem Cells.
    Alvarado-Ortiz E; Sarabia-Sánchez MÁ; García-Carrancá A
    Curr Stem Cell Res Ther; 2019; 14(5):405-420. PubMed ID: 30147013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer stem cell marker glycosylation: Nature, function and significance.
    Mallard BW; Tiralongo J
    Glycoconj J; 2017 Aug; 34(4):441-452. PubMed ID: 28624993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.
    Tanase CP; Neagu AI; Necula LG; Mambet C; Enciu AM; Calenic B; Cruceru ML; Albulescu R
    World J Gastroenterol; 2014 Aug; 20(31):10790-801. PubMed ID: 25152582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.